{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:21Z","timestamp":1772166261772,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1A5A2015061"],"award-info":[{"award-number":["2017R1A5A2015061"]}],"id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recently, FAM83H was reported to have roles in cancer progression in conjunction with oncogenic molecules such as MYC and b-catenin. Moreover, the data from the public database indicates a molecular relationship between FAM83H and zinc finger proteins, especially between FAM83H and ZNF16. However, studies on FAM83H and ZNF16 in gallbladder cancer have been limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study investigated the expression of FAM83H and ZNF16 in 105 gallbladder carcinomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In human gallbladder carcinomas, immunohistochemical expression of FAM83H was significantly associated with ZNF16 expression. In univariate analysis, nuclear and cytoplasmic expression of FAM83H or ZNF16 were significantly associated with shorter survival of gallbladder carcinoma patients. Multivariate analysis revealed the nuclear expression of FAM83H as an independent indicator of poor prognosis of overall survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.005) and relapse-free survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.005) of gallbladder carcinoma patients. Moreover, co-expression patterns of nuclear FAM83H and ZNF16 were also independent indicators of shorter survival of gallbladder carcinoma patients (overall survival;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u2009\u00a00.001, relapse-free survival;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u2009\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests FAM83H and ZNF16 are associated with the progression of gallbladder carcinoma, and the expressions of FAM83H and ZNF16 might be novel prognostic indicators of gallbladder carcinoma patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-020-00985-1","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T09:02:29Z","timestamp":1590570149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Sung Woo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae-Ri","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama Khamis","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"Do Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"See-Hyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Chul","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-4446","authenticated-orcid":false,"given":"Kyu Yun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajhg.2007.09.020","volume":"82","author":"JW Kim","year":"2008","unstructured":"Kim JW, Lee SK, Lee ZH, Park JC, Lee KE, Lee MH, Park JT, Seo BM, Hu JC, Simmer JP. FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet. 2008;82:489\u201394.","journal-title":"Am J Hum Genet"},{"key":"985_CR2","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.1002\/humu.20789","volume":"29","author":"SK Lee","year":"2008","unstructured":"Lee SK, Hu JC, Bartlett JD, Lee KE, Lin BP, Simmer JP, Kim JW. Mutational spectrum of FAM83H: the C-terminal portion is required for tooth enamel calcification. Hum Mutat. 2008;29:E95\u20139.","journal-title":"Hum Mutat"},{"key":"985_CR3","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1242\/jcs.129684","volume":"126","author":"T Kuga","year":"2013","unstructured":"Kuga T, Kume H, Kawasaki N, Sato M, Adachi J, Shiromizu T, Hoshino I, Nishimori T, Matsubara H, Tomonaga T. A novel mechanism of keratin cytoskeleton organization through casein kinase Ialpha and FAM83H in colorectal cancer. J Cell Sci. 2013;126:4721\u201331.","journal-title":"J Cell Sci"},{"key":"985_CR4","doi-asserted-by":"publisher","first-page":"26557","DOI":"10.1038\/srep26557","volume":"6","author":"T Kuga","year":"2016","unstructured":"Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, Saito Y, Koura M, Takeda Y, Matsuda J, Tomonaga T, Nakayama Y. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557.","journal-title":"Sci Rep"},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/s41598-017-03639-3","volume":"7","author":"KM Kim","year":"2017","unstructured":"Kim KM, Park SH, Bae JS, Noh SJ, Tao GZ, Kim JR, Kwon KS, Park HS, Park BH, Lee H, Chung MJ, Moon WS, Sylvester KG, Jang KY. FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC. Sci Rep. 2017;7:3274.","journal-title":"Sci Rep"},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-019-1274-0","volume":"38","author":"KM Kim","year":"2019","unstructured":"Kim KM, Hussein UK, Park SH, Kang MA, Moon YJ, Zhang Z, Song Y, Park HS, Bae JS, Park BH, Ha SH, Moon WS, Kim JR, Jang KY. FAM83H is involved in stabilization of beta-catenin and progression of osteosarcomas. J Exp Clin Cancer Res. 2019;38:267.","journal-title":"J Exp Clin Cancer Res"},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1878-0261.12016","volume":"11","author":"AM Snijders","year":"2017","unstructured":"Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach. Mol Oncol. 2017;11:167\u201379.","journal-title":"Mol Oncol"},{"key":"985_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fonc.2019.00014","volume":"9","author":"KM Kim","year":"2019","unstructured":"Kim KM, Hussein UK, Bae JS, Park SH, Kwon KS, Ha SH, Park HS, Lee H, Chung MJ, Moon WS, Kang MJ, Jang KY. The expression patterns of FAM83H and PANX2 are associated with shorter survival of clear cell renal cell carcinoma patients. Front Oncol. 2019;9:14.","journal-title":"Front Oncol"},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","volume":"23","author":"J Jen","year":"2016","unstructured":"Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23:53.","journal-title":"J Biomed Sci"},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/cddiscovery.2017.71","volume":"3","author":"M Cassandri","year":"2017","unstructured":"Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, Melino G, Raschella G. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3:17071.","journal-title":"Cell Death Discov"},{"key":"985_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/sj.leu.2404212","volume":"20","author":"H Peng","year":"2006","unstructured":"Peng H, Du ZW, Zhang JW. Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells. Leukemia. 2006;20:1109\u201316.","journal-title":"Leukemia."},{"key":"985_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"985_CR13","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102.","journal-title":"Nucleic Acids Res"},{"key":"985_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"985_CR17","volume-title":"Digestive system tumours","author":"Board WCoTE","year":"2019","unstructured":"Board WCoTE. Digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019.","edition":"5"},{"key":"985_CR18","doi-asserted-by":"crossref","unstructured":"Triner D, Castillo C, Hakim JB, Xue X, Greenson JK, Nunez G, Chen GY, Colacino JA, Shah YM. Myc-associated zinc finger protein regulates the Proinflammatory response in colitis and Colon Cancer via STAT3 signaling. Mol Cell Biol. 2018;38.","DOI":"10.1128\/MCB.00386-18"},{"key":"985_CR19","unstructured":"Amin MB, American Joint Committee on Cancer., American Cancer Society.: AJCC cancer staging manual, Eight edition \/ editor-in-chief, Mahul B. Amin, MD, FCAP ; editors, Stephen B. Edge, MD, FACS and 16 others ; Donna M. Gress, RHIT, CTR - Technical editor ; Laura R. Meyer, CAPM - Managing editor. edn. Chicago: American Joint Committee on Cancer, Springer; 2017."},{"key":"985_CR20","first-page":"155","volume":"11","author":"D Allred","year":"1998","unstructured":"Allred D, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155\u201368.","journal-title":"Mod Pathol"},{"key":"985_CR21","doi-asserted-by":"crossref","unstructured":"Kang MA, Lee J, Ha SH, Lee CM, Kim KM, Jang KY, Park SH. Interleukin4Ralpha (IL4Ralpha) and IL13Ralpha1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)\/Forkhead Box O3 (FOXO3) Pathways. Cancers (Basel). 2019;11:1394.","DOI":"10.3390\/cancers11091394"},{"key":"985_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046-018-0772-9","volume":"37","author":"HJ Park","year":"2018","unstructured":"Park HJ, Bae JS, Kim KM, Moon YJ, Park SH, Ha SH, Hussein UK, Zhang Z, Park HS, Park BH, Moon WS, Kim JR, Jang KY. The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma. J Exp Clin Cancer Res. 2018;37:107.","journal-title":"J Exp Clin Cancer Res"},{"key":"985_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0022034509349454","volume":"88","author":"Y Ding","year":"2009","unstructured":"Ding Y, Estrella MR, Hu YY, Chan HL, Zhang HD, Kim JW, Simmer JP, Hu JC. Fam83h is associated with intracellular vesicles and ADHCAI. J Dent Res. 2009;88:991\u20136.","journal-title":"J Dent Res"},{"key":"985_CR24","doi-asserted-by":"publisher","first-page":"34472","DOI":"10.1038\/srep34472","volume":"6","author":"T Kuga","year":"2016","unstructured":"Kuga T, Kume H, Adachi J, Kawasaki N, Shimizu M, Hoshino I, Matsubara H, Saito Y, Nakayama Y, Tomonaga T. Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON. Sci Rep. 2016;6:34472.","journal-title":"Sci Rep"},{"key":"985_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12033-009-9210-8","volume":"44","author":"MJ Deng","year":"2010","unstructured":"Deng MJ, Li XB, Peng H, Zhang JW. Identification of the trans-activation domain and the nuclear location signals of human zinc finger protein HZF1 (ZNF16). Mol Biotechnol. 2010;44:83\u20139.","journal-title":"Mol Biotechnol"},{"key":"985_CR26","first-page":"1131","volume":"4","author":"XB Li","year":"2011","unstructured":"Li XB, Chen J, Deng MJ, Wang F, Du ZW, Zhang JW. Zinc finger protein HZF1 promotes K562 cell proliferation by interacting with and inhibiting INCA1. Mol Med Rep. 2011;4:1131\u20137.","journal-title":"Mol Med Rep"},{"key":"985_CR27","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"985_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360.","journal-title":"Cancer Treat Rev"},{"key":"985_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-017-0001-6","volume":"3","author":"H Chen","year":"2018","unstructured":"Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduction Targeted Therapy. 2018;3:1\u20137.","journal-title":"Signal Transduction Targeted Therapy"},{"key":"985_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2018.10.003","volume":"1871","author":"E Tulchinsky","year":"2019","unstructured":"Tulchinsky E, Demidov O, Kriajevska M, Barlev NA, Imyanitov E. EMT: a mechanism for escape from EGFR-targeted therapy in lung cancer. Biochim Biophys Acta Rev Cancer. 2019;1871:29\u201339.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"985_CR31","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.18632\/oncotarget.27304","volume":"10","author":"L Croce","year":"2019","unstructured":"Croce L, Coperchini F, Magri F, Chiovato L, Rotondi M. The multifaceted anti-cancer effects of BRAF-inhibitors. Oncotarget. 2019;10:6623\u201340.","journal-title":"Oncotarget."},{"key":"985_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"KS Bhullar","year":"2018","unstructured":"Bhullar KS, Lagaron NO, McGowan EM, Parmar I, Jha A, Hubbard BP, Rupasinghe HPV. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17:48.","journal-title":"Mol Cancer"},{"key":"985_CR33","doi-asserted-by":"publisher","first-page":"16303","DOI":"10.18632\/oncotarget.11422","volume":"8","author":"AL Oei","year":"2017","unstructured":"Oei AL, Vriend LE, van Leeuwen CM, Rodermond HM, Ten Cate R, Westermann AM, Stalpers LJ, Crezee J, Kanaar R, Kok HP, Krawczyk PM, Franken NA. Sensitizing thermochemotherapy with a PARP1-inhibitor. Oncotarget. 2017;8:16303\u201312.","journal-title":"Oncotarget."},{"key":"985_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4048\/jbc.2015.18.4.329","volume":"18","author":"S Avila-Arroyo","year":"2015","unstructured":"Avila-Arroyo S, Nunez GS, Garcia-Fernandez LF, Galmarini CM. Synergistic effect of Trabectedin and Olaparib combination regimen in breast Cancer cell lines. J Breast Cancer. 2015;18:329\u201338.","journal-title":"J Breast Cancer"},{"key":"985_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1056\/NEJMe1012546","volume":"364","author":"LA Carey","year":"2011","unstructured":"Carey LA, Sharpless NE. PARP and cancer--if it's broke, don\u2019t fix it. N Engl J Med. 2011;364:277\u20139.","journal-title":"N Engl J Med"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-00985-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T19:39:56Z","timestamp":1622057996000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-00985-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-00985-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19267\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19267\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19267\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"22 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Jeonbuk National University Hospital (IRB number, CUH 2019\u201311-041) and was performed in compliance with the Declaration of Helsinki. In this approval, written informed consent was waived because of the anonymous and retrospective nature of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}